Alcohol Dependence Clinical Trial
Official title:
Comparison of Anti-craving Efficacy of Right and Left Prefrontal High Frequency rTMS in Alcohol Dependence: a Randomized Double-blind Study
Null hypothesis: There will be no significant difference in the change in craving parameters between right and left prefrontal high frequency rTMS in patients with alcohol dependence.
The patients clinically diagnosed as Alcohol dependence syndrome (F 10.24) according to
ICD-10 DCR, fulfilling the inclusion and exclusion criteria will be taken up for the study.
A detailed physical examination will be done to rule out any major medical or neurological
disease. Written informed consent will be taken after explaining the objectives and
procedure of the study in detail. To ensure that the patients selected are right handed,
Handedness Preference Schedule will be applied. Socio-demographic data will be collected.
Baseline SADQ-C and CIWA-Ar will be administered to determine the severity of alcohol
dependence and the intensity of withdrawal symptoms respectively. When the CIWA-Ar score
becomes ≤ 10, then they will be taken up for rTMS application. For these patients baseline
ACQ-NOW will be administered to measure the baseline craving. Patients will be randomly
allocated into two groups using randomization table. The first group will receive active
rTMS of the right pre-frontal cortex; the second group will be administered active rTMS of
the left pre-frontal cortex. Each patient will receive rTMS sessions 5 days a week for 2
weeks. ACQ-NOW score will again be documented in both the groups after the last rTMS session
to observe the changes in craving parameters. The rating will be done by one of the authors
who will be blind to the nature of rTMS stimulation being administered to the patients.
The motor threshold (MT) for the left abductor pollicis brevis will be determined by a
figure of 8 shaped coil, using the Rossini-Rothwell method. MT will be defined as the lowest
intensity, which produces 5 motor evoked potential (MEP) responses of at least 50 µV in 10
trials. The prefrontal cortex rTMS stimulation site will be determined by measuring 5 cm
anterior and in a parasagittal line from the point of maximum stimulation of left abductor
pollicis muscle. Ten active rTMS treatments will be administered at 10 Hz frequency, over
right or left prefrontal cortex at 110% of MT for duration of 5 seconds and 20 trains per
session, with the coil-angled tangentially to the head.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |